SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-053213
Filing Date
2012-08-01
Accepted
2012-08-01 16:06:01
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-12707_110q.htm 10-Q 2550909
2 EX-31.1 a12-12707_1ex31d1.htm EX-31.1 11399
3 EX-31.2 a12-12707_1ex31d2.htm EX-31.2 12353
4 EX-32.1 a12-12707_1ex32d1.htm EX-32.1 5569
5 EX-32.2 a12-12707_1ex32d2.htm EX-32.2 7487
  Complete submission text file 0001104659-12-053213.txt   16365044

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celg-20120630.xml EX-101.INS 2403931
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celg-20120630.xsd EX-101.SCH 148675
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celg-20120630_cal.xml EX-101.CAL 101384
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT celg-20120630_lab.xml EX-101.LAB 2400353
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celg-20120630_pre.xml EX-101.PRE 1036951
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celg-20120630_def.xml EX-101.DEF 720351
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 121000159
SIC: 2834 Pharmaceutical Preparations